HBK Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
HBK Investments's NVO Position: Q4 2018 in Review
HBK Investments sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 274,214 shares — an estimated $6.46M sold.
HBK Investments first reported a position in NVO in Q2 2013 and held it in 10 quarters. The position peaked at $11.1M in Q2 2018. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.
- HBK Investments reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
- HBK Investments sold 274,214 Novo Nordisk shares in Q4 2018, an estimated $6.46M.
- HBK Investments first reported a position in Novo Nordisk in Q2 2013 and held it in 10 quarters.
- HBK Investments's Novo Nordisk position peaked at $11.1M in Q2 2018.
- 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.
Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.